A Comprehensive Ensemble Learning Approach for Identifying Non-Small Cell Lung Cancer Through T-Cell Receptor Sequencing

Category	Detail
Condition	Non-Small Cell Lung Cancer (NSCLC)
Key Mechanisms	T-cell receptor (TCR) repertoire profiling detects tumor-associated immune responses via clonal expansion and antigen-specific TCR patterns
Target Population	Individuals at risk for or suspected of having NSCLC
Care Setting	Clinical diagnostic and screening settings, potentially non-invasive outpatient blood testing

NSCLC accounts for approximately 85% of lung cancer cases with prognosis heavily dependent on early detection.
Current screening with low-dose CT has high false-positive rates; invasive biopsy remains the diagnostic gold standard but carries risks.
A novel multi-branch ensemble learning framework integrates repertoire composition, convergent clustering, and sequence-level language modeling of TCR data to improve NSCLC detection accuracy.

Use histopathological analysis of tissue obtained by bronchoscopy or needle biopsy for definitive NSCLC diagnosis.
Consider emerging TCR repertoire sequencing as a non-invasive adjunct diagnostic tool pending further validation.

Follow established protocols for NSCLC treatment based on stage and patient condition.
Incorporate early detection strategies to improve prognosis.

Monitor high-risk individuals with annual low-dose CT screening despite its limitations.
Potential future use of TCR repertoire profiling for monitoring immune response dynamics.

Invasive biopsy procedures carry risks including pneumothorax, bleeding, and infection.
False positives from LDCT screening can lead to unnecessary interventions and patient anxiety.

Patients at risk for or suspected of NSCLC undergoing diagnostic evaluation

TCR sequencing-based diagnostics may enable earlier, less invasive detection, potentially guiding timely therapeutic interventions.

Prioritize early detection of NSCLC to improve 5-year survival rates.
Use LDCT screening in high-risk populations while acknowledging its high false-positive rate.
Employ invasive tissue biopsy for definitive diagnosis when feasible and safe.
Explore integration of TCR repertoire sequencing as a complementary, non-invasive diagnostic modality.
Leverage multi-branch ensemble learning approaches to maximize diagnostic accuracy from complex immune repertoire data.

Clinical Scorecard: A Comprehensive Ensemble Learning Approach for Identifying Non-Small Cell Lung Cancer Through T-Cell Receptor Sequencing